A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.
about
Genotyping performance between saliva and blood-derived genomic DNAs on the DMET array: a comparisonUsing miRNA-Analyzer for the Analysis of miRNA Data.DMET-analyzer: automatic analysis of Affymetrix DMET data.Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidSelf-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells.DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.Genetic variations in multiple myeloma II: association with effect of treatment.Pharmacogenomics of osteoporosis: a pathway approach.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis.Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.Analysis of miRNA, mRNA, and TF interactions through network-based methods.miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.Genetic variants associated with gastrointestinal symptoms in Fabry disease.Genetic variants associated with Fabry disease progression despite enzyme replacement therapy.Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis.Predicting paclitaxel-induced neutropenia using the DMET platform.
P2860
Q28481608-A5E55FA8-BA4A-4F05-9327-A7F698DF37BFQ31149487-63250FC5-F5C7-4F5D-892C-D8142E23D02CQ34433574-1D5D771E-9C90-42E4-87F9-85996D335625Q34786475-F010512A-2B63-426D-8B20-5FA7FFBDD37CQ36544608-564D8467-971A-44B3-957A-7E6001C99AFBQ37619866-ECDDD717-EB23-4608-8E1B-F261C0321D07Q37924890-7589242D-C836-41A4-92AA-8CFAD7669142Q38010749-E7C7D9A4-6C3C-4A22-A044-4355C7AC6ACAQ38299932-47C852D6-6042-462E-AF2E-05FEDEC47E12Q38730723-45880B74-DF7C-423B-BA8F-CF526E2B3E18Q38739527-DCB0ACDA-8814-431D-9ACE-E2A62399C331Q38854653-E1786B46-AA04-4CBF-AE0C-6A1068B0A95BQ38963137-A1808634-15E5-410D-A9DF-160D5763000BQ39223387-18A63E48-BB71-405C-9D2F-AA337B98F4DBQ42316513-74781745-289D-4EBE-854D-B2FE4695459CQ47094778-A9974BA3-3DE0-4E16-9543-E46AE0E8F4F5Q47900312-73262ADE-50B0-4CFD-B078-1CA209BC606CQ51485241-F28D3763-749C-4F3F-BAD6-385CC848763D
P2860
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A peroxisome proliferator-acti ...... by DMET microarray profiling.
@ast
A peroxisome proliferator-acti ...... by DMET microarray profiling.
@en
type
label
A peroxisome proliferator-acti ...... by DMET microarray profiling.
@ast
A peroxisome proliferator-acti ...... by DMET microarray profiling.
@en
prefLabel
A peroxisome proliferator-acti ...... by DMET microarray profiling.
@ast
A peroxisome proliferator-acti ...... by DMET microarray profiling.
@en
P2093
P2860
P50
P1476
A peroxisome proliferator-acti ...... s by DMET microarray profiling
@en
P2093
Emanuela Leone
Eugenio Piro
Francesco Baudi
Iole Cucinotto
Mariamena Arbitrio
Pierfrancesco Tassone
Pierosandro Tagliaferri
Pietro H Guzzi
Tullia Prantera
P2860
P304
P356
10.1111/J.1365-2141.2011.08622.X
P407
P577
2011-04-26T00:00:00Z